Title,Abstract,Publication_Date,Backward_Citation_Count,Forward_Citation_Count
Adjuvant chemotherapy for anaplastic gliomas,"The present invention involves the use of 2,4-disulfonyl phenyl tert-butyl nitrone (2,4-ds-PBN) in the treatment and prevention of gliomas. The 2,4-ds-PBN may be used alone or combined with other traditional chemo- and radiotherapies and surgery, to treat or prevent glioma occurrence, recurrence, spread, growth, metastasis, or vascularization.",2014-01-21,0,0
"Component mixing method, apparatus and system",A mixing device and method for mixing at least one first ingredient and at least one second ingredient. The device includes a body which has a wall defining a cavity. A first inlet communicates with the cavity for introducing the first ingredient and a second inlet communicates with the cavity for introducing the second ingredient. An outlet is provided in communication with the cavity receiving the mixed first and second ingredient which have been mixed in the cavity. The ingredients are mixed by introducing one ingredient as a stream and the second ingredient as a forcefully introduced stream. An area upstream of the ingredients is provided for mixing ingredients. Once mixed the ingredients must flow through the body before reaching the outlet. Multiple mixing devices can be cascaded to produce additional variations and mixing methods. The device can be in the form of a kit for retrofitting on existing devices such as beverage dispensers.,2014-01-07,0,0
Method of manufacturing a tunnel transistor and IC comprising the same,"A method of manufacturing a tunnel field effect transistor is disclosed. The method comprises forming a two-step profile in a silicon substrate (100) using a patterned hard mask (104) covering the higher steps of said profile; forming a gate stack (114, 116) against the side wall of the higher step; forming spacers (122) on either side of the gate stack (118); and implanting a first type impurity (124) in the higher step and an opposite type impurity in the neighboring lower step (120), wherein at least the first type impurity is implanted using an angled implanting step after removing the patterned hard mask (104). In a preferred embodiment, the method further comprises forming a sacrificial spacer (108) against a side wall of a higher step and the side wall of the hard mask (104); further etching the lower step (106, 110) next to said spacer (108) and subsequently growing a further semiconductor portion (112) on said lower step and removing the spacer (108) prior to forming the gate stack. Further disclosed is an IC comprising tunnel transistors manufactured in accordance with this method.",2014-01-28,0,0
Polypeptides having alpha-glucosidase activity and polynucleotides encoding same,"The present invention relates to isolated polypeptides having alpha-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods for producing and using the polypeptides.",2014-01-21,0,0
Multiphase metering system,"A multi-phase fluid is passed through a Coriolis flowmeter and a watercut meter. The multi-phase fluid includes two phases during a first time period and three phases during a second time period. It is determined that the multi-phase fluid includes two phases during the first time period, and a first value of a parameter of the multi-phase fluid is determined using a value measured by the Coriolis flowmeter during the first time period. A second value of a parameter of the multi-phase fluid is determined using a value measured by the watercut meter during the first time period. The first value is compared to the second value, and it is determined, based on the comparison, that the first value and the second value are inconsistent with each other.",2014-01-07,0,0
Pharmaceutical compositions comprising activated-potentiated antibodies to interferon-gamma and S100 protein,"The preset invention relates to combination pharmaceutical composition comprising an activated-potentiated from of an antibody to gamma interferon, and an activated-potentiated form of an antibody to S-100 protein and method of treating multiple sclerosis and other neurodegenerative diseases, as well as the diseases and conditions associated with neuroinfections.",2014-01-28,1,2
Production of myrtanal from beta-pinene epoxide,"The present invention refers to a process for the production of myrtanal from β-pinene epoxide that comprises at least of putting this epoxide in contact with a microporous and crystalline catalyst with pores of a diameter of at least 0.52 nm with an empirical formula for the calcinated and dehydrated form ofHw(MwTixSnyZrzSi1-w-x-y-z)O2     In the present invention, the microporous and crystalline catalyst preferably has pores of at least 0.52 nm and has a crystalline structure with an X-ray diffractogram of a zeolite beta.",2014-01-21,0,0
Method using block copolymers for making a master disk with radial binary encoded nondata marks for nanoimprinting patterned magnetic recording disks,"A method using directed self-assembly of BCPs enables the making of a master disk for nanoimprinting magnetic recording disks that have patterned data islands and patterned binary encoded nondata marks. The method uses guided self-assembly of a BCP to form patterns of sets of radial lines and circumferential gaps of one of the BCP components, which can be used as an etch mask to make the master disk. The sets of radial lines and circumferential gaps can be patterned so as to encode binary numbers. The pattern is replicated as binary encoded nondata marks into the nanoimprinted disks, with the marks functioning as binary numbers for data sector numbers and/or servo sector numbers. If the disks also use a chevron servo pattern, the binary numbers can function to identify groups of tracks associated with the chevron servo pattern.",2014-01-07,0,0
Bis-benzimidazole derivatives as hepatitis C virus inhibitors,"Inhibitors of HCV replication of formula Iincluding stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R and R′ have the meaning as defined herein.The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HCV inhibitors, in HCV therapy.",2014-01-07,0,0
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool,"Provided are a system and methods for selectively inducing expansion of a population of T cells in the absence of exogenous growth factors, such as lymphokines, and accessory cells for research purposes. The cell based expansion system and methods permit the long-term growth of CTLs, preferably human CTLs. In addition, T cell proliferation can be induced without the need for antigen, thus providing an expanded T cell population that is polyclonal with respect to antigen reactivity. Further provided are methods for using the system and methods to screen and identify antigens related to specific diseases or conditions, tumors, autoimmune disorders, or an infectious disease or pathogen, and to identify target molecule for research purposes, or for developing a vaccine based thereon.",2014-01-28,1,1
Systems and methods for administration of prescription drug benefits,"The invention relates to the administration of prescription drug formulary information. A list of drugs that a particular prescription drug plan will pay for in whole or in part is called a formulary. The invention involves the use of information and customizable rules associated with formularies, combined with information from patient medical records, to generate custom, dynamic formularies applicable to specific patients, groups of patients, or both. Depending on the choice of rules and the other information, this may help payers control prescription drug costs by encouraging the use of less-expensive drugs when medically appropriate, but without impairing the freedom of prescribers to prescribe specific drugs according to their professional judgments. Some embodiments may also be adapted to generate and store data about the use and functioning of the embodiments or aspects of them and to generate reports containing some or all such data in response to queries.",2014-01-21,0,0
Aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis,"The present invention is antibiotic compositions, ventilator-based systems and methods relating to ventilator-associated pneumonia (VAP) and ventilator-associated tracheal (VAT) bronchitis. Antibiotic combinations of fosfomycin and an aminoglycoside, preferably amikacin, are administered via an inline nebulizer within the airway of the ventilator. Humidified conditions create an improved aerosol mist to treat VAP and VAT.",2014-01-28,2,0
"Catalyst comprising an izm-2 zeolite and at least one metal, and its use in the transformation of hydrocarbons","A catalyst is described which comprises at least one IZM-2 zeolite, at least one matrix and at least one metal selected from metals from groups VIII, VIB and VIIB, said zeolite having a chemical composition expressed as the anhydrous base in terms of moles of oxides by the following general formula: XO2:aY2O3:bM2/nO, in which X represents at least one tetravalent element, Y represents at least one trivalent element and M is at least one alkali metal and/or alkaline-earth metal with valency n, a and b respectively representing the number of moles of Y2O3 and M2/nO; and a is in the range 0.001 to 0.5 and b is in the range 0 to 1.",2014-01-14,0,0
Analytic device with photovoltaic power source,"An analytical device including a sensor, an analytical circuit, and a power source. The power source includes an optical coupler formed of a light source and a photovoltaic cell for producing an electromotive force in response to light from the light source. The optical coupler is configured to provide the electromotive force to the analytical circuit. The power source may be configured for separation between the power supply and the resulting electromotive force supplied to the analytical circuit. Various aspects of the invention are directed to providing a power source for one or more components of an electrochemical detector. A method of providing power to an analytical instrument is also disclosed.",2014-01-28,0,0
G-CSF and water-soluble polymer conjugate,"Provided are a G-CSF and water-soluble polymer conjugate, or a pharmaceutically acceptable salt thereof, comprising a water-soluble polymer, a protein, and a linking group; a method for preparing thereof; and a pharmaceutical composition comprising the same.",2014-01-14,0,0
Method for determining an active dopant concentration profile,"A method for determining an active dopant concentration profile of a semiconductor substrate based on optical measurements is disclosed. The active dopant concentration profile includes a concentration level and a junction depth. In one aspect, the method includes obtaining a photomodulated optical reflectance (PMOR) amplitude offset curve and a PMOR phase offset curve for the semiconductor substrate based on PMOR measurements, determining a decay length parameter based on a first derivative of the amplitude offset curve, determining a wavelength parameter based on a first derivative of the phase offset curve, and determining, from the decay length parameter and the wavelength parameter, the concentration level and the junction depth of the active dopant concentration profile.",2014-01-21,0,0
Apparatus and method for transdermal delivery of parathyroid hormone agents,"An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers. In one embodiment, the PTH-based agent is contained in a biocompatible coating that is applied to the microprojection member.",2014-01-21,0,0
Expression vectors encoding epitopes of target-associated antigens and methods for their design,"The invention disclosed herein is directed to methods of identifying a polypeptide suitable for epitope liberation including, for example, the steps of identifying an epitope of interest; providing a substrate polypeptide sequence including the epitope, wherein the substrate polypeptide permits processing by a proteasome; contacting the substrate polypeptide with a composition including the proteasome, under conditions that support processing of the substrate polypeptide by the proteasome; and assaying for liberation of the epitope. The invention further relates to vectors including a housekeeping epitope expression cassette. The housekeeping epitope(s) can be derived from a target-associated antigen, and the housekeeping epitope can be liberatable, that is capable of liberation, from a translation product of the cassette by immunoproteasome processing. The invention also relates to a method of activating a T cell comprising contacting a substrate polypeptide with an APC and contacting the APC with a T cell.",2014-01-28,0,0
Immunogenic compounds comprising peptides of IL1β,"The present invention relates to peptides derived from the proinflammatory cytokines, interleukin-1β (IL1β) and tumor necrosis factor α (TNFα), and their use in human or veterinary therapy, such as to generally treat diseases linked to the overproduction of IL1β or TNFα as well as acute or chronic inflammatory diseases, rheumatoid arthritis, septic shock, autoimmune diabetes, graft rejection in the host, etc.",2014-01-21,0,0
Host-vector system for cloning and expressing genes,"A system for ligase-free cloning and/or expressing a target gene is described herein. A preferred version of the invention includes an E. coli host. The host preferably includes a T7 RNA polymerase gene comprising a T7gpl coding sequence, a lacUV5 promoter, and a lac operator. The host preferably further includes a lacI gene comprising a lacI coding sequence with an ATG start codon, a promoter derived from the lacql allele, and a translational enhancer derived from a 5′ RNA leader sequence of T7 gene 10. The invention further includes a low-copy plasmid vector comprising a T7 promoter a lac operator operationally linked to the T7 promoter. The system is configured to inhibit target gene expression when uninduced and to permit gene expression upon induction by auto-induction.",2014-01-07,0,0
Trigycerides containing certain saturated carboxylic acids,"Process for the production of saturated monocarboxylic acids and triglycerides of saturated carboxylic acids having more than one acid function starting from non-modified vegetable oils containing triglycerides of unsaturated fatty acids, comprising the oxidative cleavage of the unsaturated fatty acids.",2014-01-14,0,0
Glycopegylated factor IX,"The present invention provides conjugates between Factor IX and PEG moieties. The conjugates are linked via an intact glycosyl linking group interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from glycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto a glycosyl residue on the peptide. Also provided are methods for preparing the conjugates, methods for treating various disease conditions with the conjugates, and pharmaceutical formulations including the conjugates.",2014-01-21,2,0
"Fluorescence intensity correction method, fluorescence intensity calculation method, and fluorescence intensity calculation device and fluorescence intensity correction program","A fluorescence intensity correction method including: receiving fluorescence emitted from fluorescent pigments, collecting detected values from each light detector, and obtaining a fluorescence spectrum of each fluorescent pigment as one spectrum group; separating the obtained spectrum group into a plurality of small spectrum groups; comparing the separated small spectrum groups with a fluorescence wavelength distribution of each fluorescent pigment obtained in advance and specifying the small spectrum groups as the fluorescence spectrum of any fluorescent pigment; comparing a differential spectrum between small spectrum groups that are not specified and one or more specified small spectrum groups with the fluorescence wavelength distribution of unspecified fluorescent pigments obtained in advance, and specifying the differential spectrum as the fluorescence spectrum of any fluorescent pigment; and calculating the intensity of fluorescence emitted from each fluorescent pigment.",2014-01-14,0,0
Compositions and methods for treating malaria with cupredoxin and cytochrome,"The present invention relates to cupredoxin and cytochrome and their use, separately or together, to inhibit the spread of parasitemia in mammalian red blood cells and other tissues infected by the malaria parasite, and in particular the parasitemia of human red blood cells by P. falciparum. The invention provides isolated peptides that are variants, derivatives or structural equivalents of cupredoxins or cytochrome c, and compositions comprising cupredoxins and/or cytochrome c, or variants, derivatives or structural equivalents thereof, that are useful for treating or preventing malaria infection in mammals. Further, the invention provides methods to treat mammalian patients to prevent or inhibit the growth of malarial infection in mammals. The invention also provides methods to prevent the growth of malaria infection in insect vectors.",2014-01-07,0,0
Carbon nanotube transistor employing embedded electrodes,"Carbon nanotubes can be aligned with compatibility with semiconductor manufacturing processes, with scalability for forming smaller devices, and without performance degradation related to structural damages. A planar structure including a buried gate electrode and two embedded electrodes are formed. After forming a gate dielectric, carbon nanotubes are assembled in a solution on a surface of the gate dielectric along the direction of an alternating current (AC) electrical field generated by applying a voltage between the two embedded electrodes. A source contact electrode and a drain contact electrode are formed by depositing a conductive material on both ends of the carbon nanotubes. Each of the source and drain contact electrodes can be electrically shorted to an underlying embedded electrode to reduce parasitic capacitance.",2014-01-14,1,0
Inhibitors of human immunodeficiency virus replication,"The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.",2014-01-14,0,0
Plasmonic transparent conducting metal oxide nanoparticles and films for optical sensing applications,"The disclosure relates to a method of detecting a change in a chemical composition by contacting a doped oxide material with a monitored stream, illuminating the doped oxide material with incident light, collecting exiting light, monitoring an optical signal based on a comparison of the incident light and the exiting light, and detecting a shift in the optical signal. The doped metal oxide has a carrier concentration of at least 1018/cm3, a bandgap of at least 2 eV, and an electronic conductivity of at least 101 S/cm, where parameters are specified at a temperature of 25° C. The optical response of the doped oxide materials results from the high carrier concentration of the doped metal oxide, and the resulting impact of changing gas atmospheres on that relatively high carrier concentration. These changes in effective carrier densities of conducting metal oxide nanoparticles are postulated to be responsible for the change in measured optical absorption associated with free carriers. Exemplary doped metal oxides include but are not limited to Al-doped ZnO, Sn-doped In2O3, Nb-doped TiO2, and F-doped SnO2.",2014-01-28,0,0
Optical microscope and optical instrumentation,"The invention provides an optical microscope that prevents an increase in the complexity of the light source system and is equipped with optics readily capable of adequate operation even when the modulation frequency is increased in order to reduce the impact of the intensity noise of the laser, etc. This optical microscope 100 irradiates a sample 6 with a first train of optical pulses having a first optical frequency, which is generated by a first light source, and a second train of optical pulses having a second optical frequency, which is temporally synchronized with the first train of optical pulses and is generated by a second light source, and detects light scattered from the sample 6. The repetition frequency of the train of optical pulses generated by the first light source is an integral sub-multiple of the repetition frequency of the train of optical pulses generated by the second light source.",2014-01-14,0,0
Polynucleotide encoding UDP-glucuronyl transferase,"The present invention provides a novel UDP-glucuronosyltransferase and a polynucleotide encoding the same, for example, a polynucleotide comprising nucleotides 1 to 1359 of SEQ ID NO: 4, nucleotides 1 to 1365 of SEQ ID NO: 10, nucleotides 1 to 1371 of SEQ ID NO: 12, and nucleotides 1 to 1371 of SEQ ID NO: 22; or a polynucleotide encoding a protein having the amino acid sequence of SEQ ID NOS: 5, 11, 13 or 23. The invention provides a novel UDP-glucuronosyltransferase with a broad substrate specificity.",2014-01-14,1,0
Activity sensing techniques for an infusion pump system,"Some embodiments of a wearable infusion pump system can include a pump device having a drive system to dispense a medicine to a user, an activity sensor that detects a possible change in an activity level of the user, and a controller to activate the drive system to dispense the medicine to the user. The controller device can query the user to indicate whether a detected activity level of the user represents an actual change in the activity level of the user. The controller device can alter the medicine dispensing schedule based on the user indicated changes in activity level.",2014-01-07,0,0
Methods and systems for acquiring and processing veterinary-related information to facilitate differential diagnosis,"Computer-implemented methods and systems for acquiring and processing veterinary-related information, such as non-human animal diseases, associated medical signs, differentials, and treatment-related information, are provided. The disclosed methods and systems facilitate performing computer-based differential diagnosis by veterinary medicine practitioners. An example method may comprise: importing veterinary-related text information, wherein the veterinary-related text information is related to one or more non-human animal diseases; parsing the veterinary-related text information into one or more terms; determining relations between the one or more terms; classifying the one or more terms such that each term relates to one of: a non-human animal species, an animal disease, a medical sign and a treatment; and generating a database table associated with the imported veterinary-related text information, the database table comprising the one or more classified terms and the relations therebetween.",2014-01-14,0,0
Nuclear export inhibitors of topoisomerase II alpha,"A method of treating cancer in a subject comprising the step of administering to the subject in need thereof an effective amount of a combination of a compound that binds a nuclear export signal (NES inhibitor) on topoisomerase IIα and a topoisomerase inhibitor. Twenty small molecule inhibitors (SMI) that bind to the two nuclear export sequences (NES) topo IIα have been identified from the NCI database using computer-generated molecular modeling. These SMI will improve the effectiveness of topo II directed therapeutics, particularly in the treatment of diseases such as multiple myeloma (MM). In vitro apoptosis assays indicate that these drugs may be effective as single agents or in combination with currently used cancer drugs that target topo II.",2014-01-07,0,0
Amino azaheterocyclic carboxamides,"The invention provides novel substituted amino azaheterocyclic carboxamide compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.",2014-01-28,0,1
Clostridial toxin pharmaceutical composition containing a gelatin fragment,"A botulinum toxin pharmaceutical formulation comprising a botulinum toxin and a low molecular weight recombinant or native gelatin fragment suitable for administration to a human patient, and methods for treating patients with various diseases and afflictions using the formulation.",2014-01-21,0,0
Catalytic processes for preparing estolide base oils,Provided herein are processes for preparing estolides and estolide base oils from fatty acid reactants utilizing catalysts. Further provided herein are processes for preparing carboxylic esters from at least one carboxylic acid reactant and at least one olefin.,2014-01-28,0,1
Pericycle-specific expression of microrna 167 in plants,"Provided herein are compositions and methods for producing transgenic plants. In specific embodiments, transgenic plants comprise a construct comprising a polynucleotide encoding microRNA167 (miR167), or precursor thereof, operably linked to a plant pericycle-specific promote, wherein the miR167 is ectopically overexpressed in the transgenic plants, and wherein the promoter is optionally a constitutive or inducible promoter. In some embodiments, the transgenic plant has an improved agronomic or nutritional characteristic when cultivated in nitrogen-rich conditions as compared to a wild type plant cultivated in the same conditions. Also provided herein are commercial products (e.g., pulp, paper, paper products, or lumber) derived from the transgenic plants (e.g., transgenic trees) produced using the methods provided herein.",2014-01-07,0,0
Wet wiper articles and methods for cleaning removable dental appliances,"A wet wiper for cleaning accumulated oral debris from removable dental appliances. The wet wiper comprises a water insoluble substrate and a physiologically acceptable cleansing composition. Methods for cleaning removable dental appliances are also provided, such methods comprising the step of contacting, for a time sufficient to reduce oral debris, the removable dental appliances, with a wet wiper of the present invention.",2014-01-21,0,0
Systems and methods for direct communication between magnetic tunnel junctions,"Systems and methods that enable direct communications between magnetic tunnel junctions are provided. In one embodiment, a device includes multiple input magnetic tunnel junctions and an output magnetic tunnel junction. The multiple input magnetic tunnel junctions are connected in parallel, and the output magnetic tunnel junction is connected in series to the input magnetic tunnel junctions. In another embodiment, a device includes a first magnetic tunnel junction, a second magnetic tunnel junction, and a nano-magnetic channel. Each of the first and the second magnetic tunnel junctions has a free layer, a nonmagnetic layer, and a fixed layer. The nano-magnetic channel connects the free layer of the first magnetic tunnel junction to the free layer of the second magnetic tunnel junction.",2014-01-21,1,0
Soybean variety XBP05003,"A novel soybean variety, designated XBP05003 is provided. Also provided are the seeds of soybean variety XBP05003, cells from soybean variety XBP05003, plants of soybean XBP05003, and plant parts of soybean variety XBP05003. Methods provided include producing a soybean plant by crossing soybean variety XBP05003 with another soybean plant, methods for introgressing a transgenic trait, a mutant trait, and/or a native trait into soybean variety XBP05003, methods for producing other soybean varieties or plant parts derived from soybean variety XBP05003, and methods of characterizing soybean variety XBP05003. Soybean seed, cells, plants, germplasm, breeding lines, varieties, and plant parts produced by these methods and/or derived from soybean variety XBP05003 are further provided.",2014-01-28,0,0
Electric skillet with magnetic self-reversing stirrer that is removable,"A cooking skillet that provides a unique automatic stirring system for continuously stirring foods during cooking. The cooking skillet comprises a base, a receptacle, a heating element, and an automatic stirring system. The automatic stirring system comprises a stirring wand located in the receptacle and a bracket located in the base. The stirring wand and the bracket are attracted to each other through magnetic forces that provide sufficient magnetism to attract one to the other. A motor is attached to the bracket by a connecting rod and provides the means to rotate the bracket in a clockwise direction. The magnetism between the magnets in the bracket and the magnets in the stirring wand forces the stirring wand to rotate in connection with the bracket. During rotation, the stirring wand is designed to mix the food contained within the receptacle. A controlling box is used to control the power to the motor and provides a resisting sensor or reversing circuit to reverse the rotational direction of the stirring system as necessary.",2014-01-07,0,0
Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract,"The present invention provides a combination pharmaceutical composition comprising a) an activated-potentiated form of an antibody to a S-100 protein, b) an activated-potentiated form of an antibody to histamine, and c) an activated-potentiated form of an antibody to TNF-alpha. Various embodiments and variants are provided. The present invention further provides a method of treating a disease or condition of functional etiology of the gastrointestinal tract, said method comprising administering to a patient in need thereof a combination pharmaceutical composition comprising a) an activated-potentiated form of an antibody to a histamine, b) an activated-potentiated form of an antibody to S-100 protein and c) an activated-potentiated form of an antibody to TNF-alpha. Various embodiments and variants are provided.",2014-01-28,1,2
Consistency modeling of healthcare claims to detect fraud and abuse,"Transaction-based behavioral profiling, whereby the entity to be profiled is represented by a stream of transactions, is required in a variety of data mining and predictive modeling applications. An approach is described for assessing inconsistency in the activity of an entity, as a way of detecting fraud and abuse, using service-code information available on each transaction. Inconsistency is based on the concept that certain service-codes naturally co-occur more than do others. An assessment is made of activity consistency looking at the overall activity of an individual entity, as well as looking at the interaction of entities. Several approaches for measuring consistency are provided, including one inspired by latent semantic analysis as used in text analysis. While the description is in the context of fraud detection in healthcare, the techniques are relevant to application in other industries and for purposes other than fraud detection.",2014-01-28,0,0
Methods and systems for toxin delivery to the nasal cavity,Methods and systems for delivering toxin and toxin fragments to a patient's nasal cavity provide for both release of the toxin and delivery of energy which selectively porates target cells to enhance uptake of the toxin. The use of energy-mediated delivery is particularly advantageous with light chain fragment toxins which lack cell binding capacity.,2014-01-28,0,1
"Systems, methods and microrganisms for antibody production with type III secretion system","Exemplary embodiments disclosed herein include a microorganism that produces, secretes and injects recombinant antibodies into eukaryote cells said the described microorganisms can be used to prepare pharmaceutical compositions for the treatment of human or veterinary diseases.",2014-01-07,0,0
Functionalized polypeptides,"The invention provides functionalized polypeptides, especially therapeutic polypeptides (e.g., scFv), comprising a linker sequence that can be rapidly and specifically functionalized by the addition of one or functional moieties (e.g., PEG) or binding specificities (e.g., an amino acid sequence with a particular binding specificity). Such functionalized polypeptides are advantageous in that they have improved pharmacokinetic properties (e.g., improved in vivo half-life, tissue penetration and tissue residency time) over non-functionalized polypeptides. Methods for the rapid and reproducible generation of functionalized polypeptides are also provided.",2014-01-28,0,0
Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients,"Coprocessed compositions containing microcrystalline cellulose and calcium carbonate, wherein the weight ratio of microcrystalline cellulose to calcium carbonate is relatively high, are useful as excipients in the preparation of solid dosage forms containing active pharmaceutical ingredients, particularly those prepared by processes involving multiple compaction steps. Such compositions may be obtained, for example, by preparing aqueous slurries or wet masses of microcrystalline cellulose and calcium carbonate and drying such slurries or wet masses to produce particulate products. The coprocessed products exhibit improved recompactibility, as compared to coprocessed products having lower microcrystalline cellulose:calcium carbonate weight ratios or as compared to physical dry blends of the two excipients.",2014-01-21,0,0
Methods and materials for detecting contaminated food products,"This document provides methods and materials for detecting contaminated food products. For example, methods and materials for using an enzymatic amplification cascade of restriction endonucleases to detect nucleic acid of a microorganism or virus (e.g., a pathogen) within a sample (e.g., food product sample) being tested, thereby assessing a food product for possible contamination are provided.",2014-01-07,0,1
Conversion method,"A process for the preparation of water-soluble cellulose hydrolysis products, which comprises admixing cellulose with an ionic liquid in which the cellulose has at least some solubility, said ionic liquid state at a temperature at or below 150 -C, and treating the resulting solution with an acid in the presence of water, said acid having a pKa in water of less than 2 at 25 -C.",2014-01-28,0,1
MEMS-based micro and nano grippers with two axis force sensors,"The present invention relates to a design and microfabrication method for microgrippers that are capable of grasping micro and nano objects of a large range of sizes and two-axis force sensing capabilities. Gripping motion is produced by one or more electrothermal actuators. Integrated force sensors along x and y directions enable the measurement of gripping forces as well as the forces applied at the end of microgripper arms along the normal direction, both with a resolution down to nanoNewton. The microfabrication method enables monolithic integration of the actuators and the force sensors.",2014-01-07,0,0
Nematocidal sulfonamides,"Disclosed are compounds of Formula 1, N-oxides, and salts thereof,wherein    Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling a parasitic nematode comprising contacting the parasitic nematode or its environment with a biologically effective amount of a compound or a composition of the invention.",2014-01-07,0,0
Public health surveillance system,A networked system for identifying whether an individual or a plurality of individuals has been exposed to a disease-causing infectious agent associated with a bioterrorism event.,2014-01-07,0,0
Current-perpendicular-to-the-plane (CPP) magnetoresistive (MR) sensor having a top shield with an antiparallel structure,"A current-perpendicular-to-the-plane magnetoresistive sensor structure includes at least an improved top shield structure and optionally also a similar bottom shield structure. The top shield structure includes an antiparallel structure (APS) of two ferromagnetic films and a nonmagnetic antiparallel coupling (APC) film between them. The APC film induces antiferromagnetic (AF) coupling between the two ferromagnetic films so that they have their respective magnetizations oriented antiparallel. An important aspect of the APS is that there is no antiferromagnetic layer adjacent the upper ferromagnetic film, so that the upper ferromagnetic film does not have its magnetization pinned by an antiferromagnetic layer. An electroplated shield layer is formed above the APS. A nonmagnetic decoupling layer is located between the APS and the electroplated shield layer to prevent domain wall movement in the electroplated shield from transferring to the ferromagnetic layers in the APS and thus possibly induce noise in the sensor.",2014-01-28,0,0
Variant sucrose transporter polypeptides that enable faster sucrose utilization in bacteria,"Variant sucrose transporter polypeptides that enable faster sucrose utilization in bacteria are described. Additionally, variant or recombinant bacteria comprising these variant sucrose transporter polypeptides, and methods of utilizing the bacteria to produce products such as glycerol and glycerol-derived products are provided.",2014-01-14,0,0
Compounds,The present invention encompasses compounds of general formula (1)wherein,2014-01-07,0,0
"Pyrrolo[2,3-D]pyrimidine compounds","Described herein are pyrrolo[2,3-d]pyrimidine compounds, their use as Janus Kinase (JAK) inhibitors, pharmaceutical compositions containing these compounds, and methods for their preparation.",2014-01-21,0,3
"Blood glucose level information processing apparatus, blood glucose level information processing method and blood glucose level information processing program","A blood glucose level information processing apparatus, method and program provide blood glucose values and blood glucose value information within a period or range desired by a user without imposing cumbersome operation on the user. The apparatus, method and program provide blood glucose values and blood glucose value information within a period or desired range by acquiring blood glucose levels measured by a blood glucose level measuring device and date/time of measurement at which the blood glucose levels are measured, displaying a line graph obtained by plotting the blood glucose values within a predetermined period. A slide bar can also be provided, for example on a graph display screen image, whereupon if the slide bar is moved, only the blood glucose values corresponding to a preceding period backdating in response to the amount of movement of the slide bar are plotted on a line graph along a time series.",2014-01-07,0,1
Nucleic acid capable of binding to immunoglobulin G and use thereof,"The present invention provides a novel aptamer for IgG and a method for utilizing the same and the like. More specifically, the present invention provides an aptamer that binds to an Fc region of IgG (e.g., human IgG); a complex comprising an aptamer and a functional substance bound thereto (e.g., affinity substance, labeling substance, enzyme, drug, toxin, drug delivery vehicle); a solid phase carrier with an aptamer or complex immobilized thereon; medical equipment comprising a solid phase carrier; a method for antibody purification comprising adsorbing an IgG antibody to a solid phase carrier, and eluting the adsorbed IgG antibody with an eluent; a method for producing a purified antibody, comprising preparing an IgG antibody and purifying the prepared IgG antibody with a solid phase carrier and the like.",2014-01-28,0,0
"System and method for the continuous extraction of a liquid phase of microsamples, and automated installation for taking them, for carrying out the extraction and taking measurements","A continuous automated extraction system and method for physically extracting at least one liquid phase of a series of liquid microsamples which are taken beforehand in discrete packets, both in space and in time, and are in stored is provided. The method may include an extraction system having a centrifuge provided with a plurality of microholders, at least one of which is filled with the corresponding microsample and includes a filling upper portion that is extended by a separating lower portion of smaller cross section than that of the upper portion. Each filled microholder has a mass which is more than ten times the mass of this microsample, in such a way that it is possible to extract, by centrifugation, at a given instant, only a single microsample contained in a single microholder, or several microsamples contained in some or all of these microholders, progressively as the latter are filled.",2014-01-07,0,0
Electronic analyte assaying device,"The invention is an electronically processed single-step test device for detecting the presence of a preselected analyte in a fluid. The device includes a hollow rectangular outer casing, disposed within co-joined upper and lower sections of the casing are assay material, an electronic processing system, and a LCD display. The LCD display is observable through a viewing window. The assay material is a sorptive material including a fluid sample application region in the form of a sample wick in fluid communication with a test strip. The test strip includes an analyte capture region adjacent to a light shield. The electronic processing system includes red and green LEDs which are alternately pulsed or energized over predetermined periods of time to determine if fluid test results show a marker or markers in the capture region indicative of the presence of a preselected analyte in the fluid. If so, Yes+ is displayed on the LCD. If not, No− is displayed on the LCD.",2014-01-07,0,0
Colostrum composition,"The present invention relates to a composition comprising colostrum and at least one agent selected from the group of hydrocolloids, wherein said colostrum and at least one agent are bioconjugated. The bioconjugated composition has improved properties compared to colstrum compositions that are not bioconjugated with a hydrocolloid agent. The composition may be used in a variety of settings, for example for topical application for treating skin diseases and skin conditions. The present invention thus also relates to use of the composition and to a method for the preparation of the composition.",2014-01-28,0,0
Compositions comprising a fluorosurfactant and a hydrotrope,Compositions comprising a fluorosurfactant and a hydrotrope are disclosed. The hydrotropes are either cationic or anionic benzene derivatives comprising fluoro-substituted functional groups and polar groups. The compositions are useful in various surfactant applications.,2014-01-14,0,0
Genetic vasectomy by overexpression of PRML-EGFP fusion protein in spermatids,"The present invention provides a genetically-modified non-human animal whose somatic and germ cells contain an exogenous gene encoding a recombinant fusion protein, wherein the presence, and expression, of said recombinant fusion protein renders said genetically-modified non-human animal sterile. Tools for generating such sterile genetically-modified non-human animal as well as methods of use thereof are also provided.",2014-01-21,0,0
Regulating the ethylene response of a plant by modulation of F-box proteins,"The relationship between F-box proteins and proteins involved in the ethylene response in plants is described. In particular, F-box proteins may bind to proteins involved in the ethylene response and target them for degradation by the ubiquitin/proteasome pathway. The transcription factor EIN3 is a key transcription factor mediating ethylene-regulated gene expression and morphological responses. EIN3 is degraded through a ubiquitin/proteasome pathway mediated by F-box proteins EBF1 and EBF2. The link between F-box proteins and the ethylene response is a key step in modulating or regulating the response of a plant to ethylene. Described herein are transgenic plants having an altered sensitivity to ethylene, and methods for making transgenic plant having an altered sensitivity to ethylene by modulating the level of activity of F-box proteins. Methods of altering the ethylene response in a plant by modulating the activity or expression of an F-box protein are described. Also described are methods of identifying compounds that modulate the ethylene response in plants by modulating the level of F-box protein expression or activity.",2014-01-07,0,0
Lightweight thermal management material for enhancement of through-thickness thermal conductivity,"A flexible sheet of aligned carbon nanotubes includes an array of aligned nanotubes held in a polymer matrix material. The carbon nanotubes have an average length of between about 50 microns and about 500 microns. The polymer matrix has an average thickness of between about 10 microns and about 500 microns. The flexible sheet has a density of about 0.2 to about 1.0 g/cc and includes between about 98 to about 60 weight percent aligned carbon nanotubes and between about 2 and about 40 weight percent polymer. A tape of aligned carbon nanotubes, a method for producing a tape of aligned carbon nanotubes, a method of producing the flexible aligned carbon nanotube sheet material and a method of increasing unidirectional heat conduction from a work piece are also disclosed.",2014-01-21,0,1
"Anti-arthropod vector vaccines, methods of selecting and uses thereof",The present disclosure provides methods of selecting and uses of anti-arthropod vector vaccines to prevent Leishmaniasis. The present disclosure also provides compositions for vaccines to prevent Leishmaniasis.,2014-01-14,0,0
Drug-carrying contact lens and method for fabricating the same,"The present invention discloses a drug-carrying contact lens and a method for fabricating the same. The drug-carrying contact lens comprises a contact lens containing at least one amphiphatic hybrid nanocarrier carrying drug molecules. According to the heat or light sensitivity of the drug molecule, the present invention respectively fabricates an encapsulation-type drug-carrying contact lens and a drug-soaking type drug-carrying contact lens. The present invention uses a highly-biocompatible amphiphatic hybrid nanocarriers having superior drug encapsulation capability to wrap the drug molecules. Thereby, the drug molecules are uniformly distributed in the contact lens and can be gradually and locally released to the eye of the user wearing the contact lens. Therefore, the present invention can prevent or cure ocular diseases with the loss and side effects of the drug being reduced.",2014-01-07,0,0
"Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, and preparation method and use thereof","A Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, comprising first type medicinal material and second type medicinal material. The first type medicinal material includes Rhizoma Bletillae, Cortex Cinnamomi, Radix Angelicae Formosanae, Radix Angelicae Sinensis, Paeonia Lactiflora, Rhizoma Notopterygii, Radix Linderae, Glycyrrhizae, Radix Angelicae Pubescentis, and Radix Et Rhizoma Rhei. The second type medicinal material includes one, two, or three selected from the group consisting of Zingiber Officinale, Olibanum, and Myrrha. The preparation method for the Chinese herbal medicine composition includes adding the first type medicinal material and the second type medicinal material into a container with organic solvent, heating, filtering, and then condensing the filtrate into an extractum.",2014-01-21,0,0
4-aminoindole derivatives and use thereof for the oxidation dyeing of keratin fibres,"The invention relates to 4-aminoindole derivatives of formula (I), and the addition salts thereof, mesomers thereof, isomers thereof and solvates thereof: and to their use for the oxidation dyeing of keratin fibers, and in particular of human keratin fibers such as the hair. The present invention makes it possible to achieve dark shades, natural shades and dark natural shades. The present invention also makes it possible to obtain powerful, chromatic, aesthetic, sparingly selective coloration of keratin fibers in varied shades, which is resistant to the various attacking factors to which the hair may be subjected. In particular, when the 4-aminoindole derivatives are combined with one or more heterocyclic oxidation bases, they make it possible to obtain a wide range of colors and coloration of keratin fibers that shows good chromaticity and good selectivity.",2014-01-07,0,0
Magnetic sensor including a free magnetization layer and a fixed magnetization layer on a nonmagnetic conductor,"A magnetic sensor comprises a support; a nonmagnetic conductive layer disposed on the support; a fixed magnetization layer disposed on a first part of the nonmagnetic conductive layer and on the support; a free magnetization layer disposed on a second part of the nonmagnetic conductive layer different from the first part and on the support; and a nonmagnetic low resistance layer, disposed on a part overlapping the nonmagnetic conductive layer in at least one of the fixed magnetization layer and free magnetization layer, having an electrical resistivity lower than that of the one layer.",2014-01-28,2,0
EphA3 antibodies for the treatment of solid tumors,The invention provides methods and compositions comprising anti-EphA3 antibodies for the treatment of solid tumors.,2014-01-28,0,0
Compositions including triciribine and trastuzumab and methods of use thereof,"This application relates to combination therapies including triciribine and related compounds and trastuzumab or a salt thereof and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.",2014-01-07,0,0
System and methods for generating a brightfield image using fluorescent images,"A method for generating a brightfield type image, which resembles a brightfield staining protocol of a biological sample, using fluorescent images is provided. The steps comprise acquiring two or more fluorescent images of a fixed area on a biological sample, mapping said fluorescent image into a brightfield color space, generating a brightfield image, and optionally applying a sharpening transformation correction. Also provided is an image analysis system for generating a brightfield type image of a biological sample using fluorescent images.",2014-01-28,0,1
Compositions comprising estolide compounds and methods of making and using the same,"Provided herein are compositions comprising at least one estolide compound of formula:in which n is an integer equal to or greater than 0; m is an integer equal to or greater than 1; R1, independently for each occurrence, is selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; R2 is selected from hydrogen and optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched; and R3 and R4, independently for each occurrence, are selected from optionally substituted alkyl that is saturated or unsaturated, and branched or unbranched. Also provided are uses of the compositions described herein.",2014-01-21,0,3
Formoterol/steroid bronchodilating compositions and methods of use thereof,"Bronchodilating compositions and methods are provided. The compositions are intended for administration as a nebulized aerosol. In certain embodiments, the compositions contain formoterol, or a derivative thereof, and a steroidal anti-inflammatory agent. Methods for treatment, prevention, or amelioration of one or more symptoms of bronchoconstrictive disorders using the compositions provided herein are also provided.",2014-01-07,0,0
Integrin targeted synthetic ligands for diagnostic and therapeutic applications,"The present invention relates to a novel class of diagnostically or therapeutically effective compounds comprising novel aza-bicycloalkane based cyclic peptides, acting as a targeting moiety towards integrin receptors.",2014-01-28,0,0
Light emitting diode,"A light emitting diode includes a second electrode, a first semiconductor layer, an active layer, a second semiconductor layer, a reflector, and a first electrode. The second electrode, the first semiconductor layer, the active layer, the second semiconductor layer, and the reflector are stacked on the first electrode in that order. The first semiconductor layer defines a plurality of grooves on a surface contacting the second electrode. The plurality of grooves form a patterned surface used as the light extraction surface. A carbon nanotube layer is located on the patterned surface and embedded into the grooves.",2014-01-21,0,0
Electrophoretic device for separation of charged molecules using a petri dish,The present invention provides a portable circular electrophoretic device having uniform electric field over a small surface area. It also provides a multidirectional process of electrophoresis for separation of charged molecules thereby increasing the resolution of macromolecules.,2014-01-14,0,0
Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces,"The presently disclosed subject matter relates to peptides having binding affinity for glycopeptide antibiotics and methods and compositions for delivering glycopeptide antibiotic to the surface of medical devices. The peptide compositions can comprise a peptide having binding affinity for a surface material of a medical device that is coupled to the peptide having binding affinity for glycopeptide antibiotic. Also provided are methods of applying the peptide compositions to a medical device by contacting the peptide compositions with a surface of the medical device. In addition, kits are provided comprising the peptide compositions.",2014-01-28,0,0
Multilayer hard magnet and data storage device read/write head incorporating the same,"A hard magnet may include a seed layer including a first component including at least one of a Pt-group metal, Fe, Mn, and Co, a cap layer comprising the first component, and a multilayer stack between the seed layer and the cap layer. In some embodiments, the multilayer stack may include a first layer of including the first component and a second component including at least one of a Pt-group metal, Fe, Mn, and Co, where the second component is different than the first component. The multilayer stack may further include a second layer formed over the first layer and including the second component, and a third layer formed over the second layer and including the first component and the second component.",2014-01-21,0,0
Method for the detection and/or identification of a microorganism,"The present invention relates generally to a method of identifying micro-organisms in a sample and in particular to the identification of prokaryotic micro-organisms. In some embodiments, the present invention relates to a method for the detection and/or identification of at least one microorganism or for the simultaneous detection and/or identification of several microorganisms in a test sample wherein the test sample is contacted with one or more probes derived from a tuf gene variable region.",2014-01-21,0,0
MRI thermometry combined with hyperpolarisation device using photons with orbital angular momentum,"A magnetic resonance examination system comprises an RF-system for inducing resonance in polarized dipoles and receiving magnetic resonance signals from an object to be examined. A thermometry module dervies a temperature distribution of the object to be examined from the magnetic resonance signals. The magnetic resonance examination system further comprises a photonic-based hyperpolarization device with a photonic source for emitting electromagnetic radiation, a moder converter, such as a phase hologram to impart orbital angular momentum to the electromagnetic radiation and via spatial filter to select from the phase hologram a diffracted photonic beam endowed with orbital angular momentum for polarizing the dipoles via transferred orbital angular momentum.",2014-01-28,0,0
Methods and devices for single-molecule whole genome analysis,"Provided are methods and devices for single-molecule genomic analysis. In one embodiment, the methods entail processing a double-stranded nucleic acid and characterizing said nucleic acid. These methods are useful in, e.g., determining structural variations and copy number variations between individuals.",2014-01-14,0,1
Apparatus and method for non-intrusive assessment of gas in packages,"A method and apparatus are disclosed for assessment of a sealed package. Light is emitted from a narrow-band laser source towards said package from outside of said package. An absorption signal of said light scattered in said package is measured, wherein said absorption is caused by said at least one gas when said light is scattered and travels in said sealed package. Measuring is made outside of said package, whereby said assessment is non-intrusive with regard to said package. It is determined if a deviation exists from a predetermined, expected gas composition and/or concentration of said at least one gas within said sealed package based on said measured absorption signal. Thus sealing of said package for said gas is detected.",2014-01-28,0,0
Rare earth alumina particulate manufacturing method and application,"A rare earth alumina particulate composition manufacturing method and application are disclosed. The rare earth alumina of the invention is a particulate of porous structure with a molecular formula (REx,Al1-x)2O3, phase γ or γ+δ characterized by a particle size distribution ranging from 1 to 80 μm with a D50 of 5 to 15 μm, a pore size distribution ranging from 0.4-200 nm with an average pore diameter of 8 to 30 nm, a pore volume (PV) raging from 0.5 to 1.2 cc/g and a fresh specific surface area (SA) ranging from 130 to 250 m2/g after calcination at 500-900° C. for 5 to 10 hours. The rare earth alumina retains a SA of greater than 60 m2/g after calcination at 1200° C. for 4 hours and greater than 40 m2/g after calcination at 1200° C. for 50 hours. There is no presence of the α phase or other impurity phases in the long-term aged samples. The rare earth alumina of the invention has a high thermal stability and is a fine three-way catalyst support material. The rare earth alumina is made using wet continuous coprecipitation with a static mixer and a tank reactor featuring simple operation, low cost and high feasibility in industrial production.",2014-01-14,0,0
PACS optimization techniques,"Some embodiments provide a method and system for efficiently transferring medical images. Some embodiments receive a medical image in a first platform dependent format of a Picture Archiving and Communication System (PACS). The first platform dependent format is one that is accessible by a first format compliant device that includes a library that specifies how to decode the first format. Some embodiments transform the medical image from the first format to a second format. The second format includes decoded content of the first format that is viewable on a first format non-compliant device. The transformed image is then passed to the device for viewing. Additionally, some embodiments efficiently transfer medical images by identifying image settings for one or more devices and by passing requested images that are optimized by resizing the images according to the image settings of the requesting device.",2014-01-21,0,0
Diazeniumdiolate cyclohexyl derivatives,"A compound having the structure (I) or a pharmaceutically acceptable salt thereof, wherein R3 is hydrogen, deuterium, —OH, —OC1-6alkyl, or halogen; R8 is hydrogen, deuterium, or C1-6alkyl; R11 and R12 are independently hydrogen, —C1-6alkyl, —OH, —OC1-6alkyl, or halogen; R13 and R14 are independently —C1-6alkyl, —(CH2)1-2OH, or —OC1-6alkyl, or, together with the nitrogen atom to which they are attached, form a 4- to 7-membered heterocyclic ring containing one nitrogen atom and 0 or 1 oxygen atoms, wherein said ring is unsubstituted or mono-, di- or tri-substituted with halogen or —C1-6alkyl; R15 is —C(O)OH, —C(O)OCH2CH2N+CH3)3 wherein n is 0, 1 or 2, —C(O)NHCH(R17)OR16, or —C(O)NHCH(R17)C(O)NHCH(R18)C(O)OR16; R16 is hydrogen, C1-6alkyl, or (CH2)1-2N+R19R20R21; R1, R2, R4, R5, R6, R7, R9, R10, R17, R18, R19, R20, and R21 are independently hydrogen or —C1-6alkyl; and stereoisomers thereof, and pharmaceutically acceptable salts thereof, and pharmaceutically acceptable salts of stereoisomers thereof.",2014-01-07,0,0
"Compositions, kits and methods for detection of Campylobacter nucleic acid","The disclosed invention is related to compositions, kits and methods comprising one or more oligomers targeting 16S rRNA target nucleic acid from Campylobacter species jejuni, coli and/or lari. Compositions include amplification oligomers, detection probe oligomers and/or target capture oligomers. Kits and methods comprise at least one of these oligomers.",2014-01-28,0,0
Defect inspecting method and defect inspecting apparatus,"Provided are a defect inspecting method and a defect inspecting apparatus, wherein defect detecting sensitivity is improved and also haze measurement is performed using polarization detection, while suppressing damages to samples. The defect inspecting apparatus is provided with a light source which oscillates to a sample a laser beam having a wavelength band wherein a small energy is absorbed, and two independent detecting optical systems, i.e., a defect detecting optical system which detects defect scattered light generated by a defect, by radiating the laser beams oscillated by the light source, and a haze detecting optical system which detects roughness scattered light generated due to roughness of the wafer surface. Polarization detection is independently performed with respect to the scattered light detected by the two detecting optical systems, and based on the two different detection signals, defect determination and haze measurement are performed.",2014-01-28,0,0
Method for activating natural killer cells by tumor cell preparation in vitro,The present invention provides a method for activating a Natural Killer (NK) cell by contacting the NK cell in vitro with an activating tumor cell preparation (ATCP). The invention also provides an activated NK cell produced by such a method and its use in the treatment of cancer.,2014-01-28,0,0
Modified factor VIII and factor IX genes and vectors for gene therapy,The present invention relates to a modified and optimized Factor VIII or Factor IX nucleic acid for inclusion in a chimeric virus vector. Use of such vector can be used for treatment of hemophilia.,2014-01-21,0,0
Substituted pyridyl amide compounds as modulators of the histamine H3 receptor,Certain substituted pyridyl amide compounds are histamine H3 receptor modulators useful in the treatment of histamine H3 receptor-mediated diseases.,2014-01-28,0,0
Apparatus and method for sterilizing seed beds in soil,An apparatus and a method are described for sterilizing seed beds in soil. The apparatus is comprised of at least one hot water injecting chamber defined by a pair of spaced-apart side walls secured to one another and defining therebetween a passage. A plurality of jet holes are provided in an inner surface of each of the side walls and facing the direction of the passage. The jet holes communicate with a manifold associated with each side wall which is connected to a supply of pressurized hot water. Each of the side walls is configured to penetrate into the soil in at least a lower region thereof whereby to inject into the soil in the passage between the pair of plates the pressurized hot water as the hot water injecting chamber is displaced in the soil.,2014-01-07,0,0
Real-time completion monitoring with acoustic waves,"A method for monitoring fluid flow through a downhole device, comprises a) providing an acoustic tube wave in fluid in the device; b) measuring the acoustic tube wave after it has passed through the fluid in the device; and c) assessing the permeability of the device by measuring the attenuation of the acoustic signal. Changes in velocity of the acoustic signal may also be measured. The device may be a permeable downhole device such as a sand screen the measurements in step b) are made using a plurality of sensors deployed in the hole. The method may further including the step of cross-correlating a signal received at a first receiver with signals received at additional sensors so as to obtain an effective response as if the signal had been emitted from a source at the position of said first receiver.",2014-01-28,0,0
Light emitting and lasing semiconductor devices and methods,"A semiconductor light emitting device, including: a heterojunction bipolar light-emitting transistor having a base region between emitter and collector regions; emitter, base, and collector electrodes for coupling electrical signals with the emitter, base, and collector regions, respectively; and a quantum size region in the base region; the base region including a first base sub-region on the emitter side of the quantum size region, and a second base sub-region on the collector side of the quantum size region; and the first and second base sub-regions having asymmetrical band structures.",2014-01-28,0,0
Process for producing L-amino acid,"The present invention provides a method of improving efficiency of a fermentative production of an L-amino acid. To be specific, the present invention provides a process for producing a L-amino acid, comprising culturing a microorganism wherein the activity of the protein described in any one of (1) to (3) below is higher than that of the parent strain in a medium to produce the L-amino acid and accumulate the L-amino acid in the medium, and then collecting the L-amino acid from the medium:",2014-01-07,0,0
"Sensor device, motion sensor, and electronic device","A sensor device includes a first electrode disposed on active surface side of a silicon substrate, an external connecting terminal electrically connected to the first electrode, at least one stress relaxation layer disposed between the silicon substrate and the external connecting terminal, a connecting terminal disposed on the active surface side of the silicon substrate, and a vibration gyro element having weight sections as mass adjustment sections, the vibration gyro element is held by the silicon substrate due to connection between the connection electrode and the external connecting terminal, and a meltage protection layer formed in an area where the stress relaxation layer and the mass adjustment section overlap each other in a plan view is provided.",2014-01-21,1,0
Nicotiana nucleic acid molecules and uses thereof,"The present invention features Nicotiana nucleic acid sequences such as sequences encoding constitutive, or ethylene or senescence induced polypeptides, in particular cytochrome p450 enzymes, in Nicotiana plants and methods for using these nucleic acid sequences and plants to alter desirable traits, for example by using breeding protocols.",2014-01-28,1,0
Method for biotechnological production of a hydrogen carrier,"The invention relates to a method for biotechnological production of a hydrogen carrier. It is proposed to culture ammonium-producing cyanobacteria in which, by increasing the nitrogenase activity and/or blocking the utilization of ammonium in the cell metabolism and/or providing an exit mechanism for ammonium via the cell membrane, the ammonium yield is increased. The ammonia generated by the cyanobacteria is made available as a hydrogen carrier.",2014-01-07,0,0
Methods of detecting antibodies specific for denatured HLA antigens,"The invention is directed to methods of screening for HLA antibodies comprising detecting antibodies specific for native HLA antigens and denatured HLA antigens. The invention also provides for methods of removing antibodies specific for denatured HLA antigens or antibodies specific for native HLA antigens from a serum sample. In addition, the invention also provides for method of predicting whether a transplant recipient has an increased risk for rejecting the transplanted organ.",2014-01-14,0,0
Anti-cancer agents,"Described herein are compounds that may be selectively activated to produce active anti-cancer agents in tumor cells. Also disclosed are pharmaceutical compositions comprising the compounds, and methods of treating cancer using the compounds.",2014-01-28,0,0
Nano-PCR: methods and devices for nucleic acid amplification and detection,"Methods, devices, and compositions are described that provide for amplification of nucleic acid sequences without reliance upon temperature cycling, thus freeing the methods from conventional benchtop thermal cycling devices. Denaturation of double stranded nucleic acids, primer annealing, and precision control over primer extension by polymerase can be accomplished by applying stress to a nucleic acid. These methods can provide one or more benefits over conventional PCR methods including: precision control over the PCR process; generally improved fidelity; improved accuracy over problematic sequences such as GC-rich or tandem repeat regions; greater sequence length; increased reaction yield; reduced experimental time; greater efficiency; lower cost; greater portability; and, robustness to various environmental parameters, such as temperature, pH, and ionic strengths.",2014-01-21,0,0
Indenter assembly,"An indentation assembly for sub-micron testing includes an indentation tip and a tip holder coupled with the indentation tip. The tip holder includes a first thermal conductivity and a first coefficient of thermal expansion. A tip holder mount configured for coupling with a transducer and the tip holder, the tip holder mount having a second thermal conductivity greater than the first thermal conductivity, and the tip holder mount has a second coefficient of thermal expansion greater than the first coefficient of thermal expansion. The tip holder mount has a mount length, and the tip holder further has a tip holder length greater that the mount length. The tip holder remotely positions the tip holder mount relative to the indentation tip. The tip holder length, volume and the first thermal conductivity cooperate to throttle heat transfer through the tip holder prior to reaching the tip holder mount.",2014-01-21,0,2
Process for mixing wellbore fluids,"A method for mixing a drilling fluid formulation that includes establishing a flow path for a base fluid, adding drilling fluid additives to the base fluid to create a mixture, aerating the mixture of base fluid and drilling fluid additives, and injecting a compressible driving fluid into the mixture of base fluid and drilling fluid additives to form a mixed drilling fluid is disclosed.",2014-01-07,0,0
Peroxisome proliferator-activator receptor δ (PPARδ) and the development of preimplantation embryos,"Methods and compositions for enhancing development of a preimplantation mammalian embryo and for increasing the live birth potential of an in vitro fertilized mammalian embryo are disclosed. An in vitro method of activating the peroxisome proliferator activated receptor δ (PPARδ) in a preimplantation mammalian embryo comprises culturing an embryo in an embryo culture medium, and upon or after commencement of expression of PPARδ in the cells of the embryo, activating the PPARδ by adding an amount of a PPARδ ligand to said medium effective to bind to PPARδ to deter apoptosis in the cells of the cultured embryo and/or increase proliferation of the cells of the cultured embryo.",2014-01-21,0,0
Hair conditioning composition,"The present invention is a hair conditioning composition includes approximately 40,000 IU of Vitamin E oil from 2 fl. oz., approximately 2 fl. oz. of 100% pure Australian tea tree oil, approximately 4 fl. oz. of Jojoba oil, approximately 32 oz. of pure extra virgin organic coconut oil with 62 percent MCT's and approximately 4 fl. oz. of 100 percent cold pressed sweet almond oil. The hair conditioning composition also includes approximately 4 fl. oz. of 100 percent pure Vitamin E, approximately 16 fl. oz. of cold pressed paraben free hexane free castor oil, approximately 16 fl. oz. of 100 percent moisturizing sweet almond oil and a plurality of avocados and whole aloe Vera plants weighing approximately 10 pounds of 100 percent pure fresh cut whole grown aloe Vera fresh plants.",2014-01-21,0,0
"Silicon carbide substrate, semiconductor device, method of manufacturing silicon carbide substrate and method of manufacturing semiconductor device","A main surface of a silicon carbide substrate is inclined by an off angle in an off direction from {0001} plane of a hexagonal crystal. The main surface has such a characteristic that, among emitting regions emitting photoluminescent light having a wavelength exceeding 650 nm of the main surface caused by excitation light having higher energy than band-gap of the hexagonal silicon carbide, the number of those having a dimension of at most 15 μm in a direction perpendicular to the off direction and a dimension in a direction parallel to the off direction not larger than a value obtained by dividing penetration length of the excitation light in the hexagonal silicon carbide by a tangent of the off angle is at most 1×104 per 1 cm2. Accordingly, reverse leakage current can be reduced.",2014-01-07,0,0
Conversion of biomass feedstocks into hydrocarbon liquid transportation fuels,"Methods for converting a carbon-containing feedstock into a fluid transportation fuel are described. The methods may include converting the carbon-containing feedstock into a producer gas comprising H2, CO, CO2, and N2, and reacting the producer gas with a substrate catalyst to produce a combination of Fischer-Tropsch (F-T) products, the F-T products including the fluid transportation fuel. A portion of the F-T products may be catalytically cracked to produce additional amounts of the fluid transportation fuel. A portion of the F-T products may also be hydrogenated to produce additional amounts of the fluid transportation fuel. Apparatuses are also described or converting a carbon-containing feedstock into a fluid transportation fuel. The apparatuses may include a producer gas reactor, a Fischer-Tropsch reactor, a cracking reactor, and a hydrogenation reactor.",2014-01-07,0,0
Systems and methods for collecting tear film and measuring tear film osmolarity,"A sample receiving chip comprising a substrate that receives an aliquot volume of a sample fluid and a sample region of the substrate, sized such that the volume of the sample fluid is sufficient to operatively cover a portion of the sample region. The energy imparted into the sample fluid is transduced by the sample region to produce an output signal that indicates energy properties of the sample fluid. The sample receiving chip also includes a channel formed in the substrate, the channel configured to collect the aliquot volume of a sample fluid and transfer the aliquot volume of sample fluid to the sample region.",2014-01-14,0,0
Method for recording an X-ray image and X-ray system,"In order to optimize the recording time, provision is made of a method for recording an X-ray image using an X-ray system with an X-ray detector, an X-ray source, a system control, and a computational unit, wherein information relating to the relative direct radiation component in a reference X-ray image and information relating to the utilized recording geometry and/or the utilized primary X-ray dose and/or the utilized filtering is used to determine a relaxation time, during which a ghosting effect of the X-ray detector resulting from a preceding X-ray image decays at least in part, which relaxation time is adapted to the X-ray image to be recorded, and the determined relaxation time is utilized to actuate the recording of the X-ray image.",2014-01-14,0,0
Scar and rosacea and other skin care treatment composition and method,"The present invention relates generally to composition and methods for topical application to skin. More particularly, it relates to treatment of scars and rosacea, and other aspects of skin care. A composition is disclosed having a skin toner for cleansing a skin surface, removing dead skin cells, restoring alkali balance, and shrinking skin pores; and a skin moisturizer for increasing water content in the external layers of the skin.",2014-01-07,0,1
Targeted particles and methods of using the same,Drug delivery compositions and methods of delivering compounds are disclosed. Vaccines and methods of immunizing individuals are disclosed. Compositions for drug delivery including gene therapy and methods of treating individuals using such compositions are disclosed.,2014-01-28,0,0
Hair colouring methods and compositions thereof,The present invention relates to a method for coloring hair wherein a hair coloring composition is applied to the hair roots. The hair coloring composition is then diluted with a dilutant component and the diluted hair coloring composition is applied to the hair lengths and tips.,2014-01-21,1,0
"Phospholipases, nucleic acids encoding them and methods for making and using them","The invention provides novel polypeptides having phospholipase activity, including, e.g., phospholipase A, B, C and D activity, patatin activity, phosphatidic acid phosphatases (PAP) and/or lipid acyl hydrolase (LAH) activity, nucleic acids encoding them and antibodies that bind to them. Industrial methods, e.g., oil degumming, and products comprising use of these phospholipases are also provided.",2014-01-28,0,0
Methods of forming visual hydrogen detector with variable reversibility,"Methods, processes and compositions are provided for a visual or chemochromic hydrogen-detector with variable or tunable reversible color change. The working temperature range for the hydrogen detector is from minus 100° C. to plus 500° C. A hydrogen-sensitive pigment, including, but not limited to, oxides, hydroxides and polyoxo-compounds of tungsten, molybdenum, vanadium, chromium and combinations thereof, is combined with nano-sized metal activator particles and preferably, coated on a porous or woven substrate. In the presence of hydrogen, the composition rapidly changes its color from white or light-gray or light-tan to dark gray, navy-blue or black depending on the exposure time and hydrogen concentration in the medium. After hydrogen exposure ceases, the original color of the hydrogen-sensitive pigment is restored, and the visual hydrogen detector can be used repeatedly. By changing the composition of the hydrogen-sensitive pigment, the time required for its complete regeneration is varied from a few seconds to several days.",2014-01-07,0,0
Pigment-based inkjet inks,"An inkjet ink composition comprising: (a) water; (b) dispersed pigment particles; and (c) at least one humectant; wherein the pigment particles are present from about 4.5% by mass to about 10% by mass, and the pigment particles have a mass weighted mean Stoke's diameter of from about 35 nm to about 70 nm wherein the Stoke's diameter is determined by differential centrifugal sedimentation of the particles through a fluid in a disc centrifuge. The present invention employs specified sedimentation particle sizing criteria for selection of appropriate pigment particle sizes at high pigment concentrations to obtain improved ink performance. Further embodiments of the invention also demonstrate that the criticality of humectant types and levels employed in an ink can also become much more important at high pigment loading in order to obtain desired performance.",2014-01-07,1,0
Modulation of chemosensory receptors and ligands associated therewith,"The present invention includes methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors, and modifiers capable of modulating chemosensory receptors and their ligands. The present invention also includes modifiers of chemosensory receptors and their ligands having Formula (I), its subgenus, and specific compounds. Furthermore, the present invention includes ingestible compositions comprising the modifiers of chemosensory receptors and their ligands and methods of using the modifiers of chemosensory receptors and their ligands to enhance the sweet taste of an ingestible composition or treat a condition associated with a chemosensory receptor. In addition, the present invention include processes for preparing the modifiers of chemosensory receptors and their ligands.",2014-01-21,1,0
Production of polyurethane foams,"The invention relates to a process for producing polyurethane foams, by frothing and drying mixtures of specific polyurethane dispersions and crosslinkers.",2014-01-14,0,0
Anti-obesity agent and anti-obesity food,"An anti-obesity agent containing, as an active ingredient, a microorganism which belongs to the species Lactobacillus reuteri and is capable of producing lipases having the amino acid sequences respectively depicted in SEQ ID NO: 1, 3 or 5 or amino acid sequences having deletion, substitution or addition of one or more amino acids in the amino acid sequences respectively depicted in SEQ ID NO: 1, 3 or 5. The anti-obesity agent enables a patient to take a normal meal yet preventing the absorption of a fat into the body which is the primary cause of obesity.",2014-01-28,0,0
"Nanoparticle biosensor, method of preparing same and uses thereof","The invention relates to the field of biosensors and, more specifically, to nanoparticle biosensors comprising: a magnetic core, a silica layer, one or more outer metal layers which can be of different types and deposited in an alternating manner and immobilized on the outer surface, and a layer of synthetic or natural organic or inorganic biosensor molecules that can bind to biomolecules. The invention also relates to a method of obtaining the nanoparticle biosensors as well as to the different uses thereof.",2014-01-07,0,0
Wafer formulation,An orally administrable wafer is provided comprising at least one physiologically acceptable film forming agent. The wafer is formed by mixing the film-forming agent with an aqueous solution to form a gel and exposing the gel to a plurality of heating and cooling cycles. The wafer is rapidly dissolving and suitable for administration of pharmaceutical agents.,2014-01-07,0,0
Siderophore-mediated iron uptake in bacterial infection,"The present invention relates to methods of inhibiting S. aureus comprising inhibiting siderophore-mediated iron uptake, for example, staphyloferrm-mediated iron uptake Such methods of inhibiting S. aureus include the inhibition of staphyloferrm A- and staphyloferrm B-mediated uptake either by inhibiting expression or activity of staphyloferrm A and B or by inhibiting transport of staphyloferrm A and B The methods as provided would be useful for treating S. aureus infection.",2014-01-28,0,0
Medication advisory system,"A medication information repository and analysis system receives prescription information indicating medication prescriptions filled for the patient, analyzes the prescription information to determine an estimate of recent medication consumption by the patient, and stores a medication advisory message indicating prescription and recent medication consumption information for the patient in association with a personal identifier assigned to the patient. A medication advisory delivery system automatically delivers the medication advisory message in response to a medication advisory request that is received in accordance with medication advisory contact information and indicates the personal identification number assigned to the patient. An emergency medical technician may issue the medication advisory request after reading a medication advisory tag carried by a patient identifying the medication advisory contact information and the personal identifier assigned to the patient.",2014-01-28,0,0
"Clear carrier compositions for lipophilic compounds, and method of treating keratinous substrates using such compositions","The present invention relates to a composition comprising:    Such a composition is clear in appearance, and stable.The present invention also relates to a method of making such a clear composition, and to a method of cosmetic treatment of a keratinous substrate using such a composition.",2014-01-28,0,0
Production of synthesis gas by heating oxidized biomass with a hot gas obtained from oxidation of residual products,"A process for producing synthesis gas, or syngas, from biomass. The process comprises contacting biomass with oxygen, or oxygen and steam, in an amount effective to oxidize the biomass and to heat the biomass to a temperature to no greater than 750° C. At least one combustible material also is contacted with oxygen and steam to heat the at least one combustible material to a temperature of at least 1,100° C., to provide a hot gas derived from the oxidized combustible material. The latter maybe residual products derived from the process itself as char, tar, or hydrocarbons. The oxidized biomass then is contacted with the hot flue gas to heat the biomass to a temperature of at least 900° C., thereby producing synthesis gas. The synthesis gas then is recovered. Such process provides a method of providing heat for producing synthesis gas without consuming a portion of the synthesis gas to provide such heat, thereby providing an increased yield of synthesis gas.",2014-01-28,0,0
"Adduct of 1-hydroxyethylidene-1, 1-diphosphonic acid and ethylenediamine disuccinic acid or a salt thereof, a method for its preparation, and the use of said adduct","An adduct of 1-hydroxyethylidene-1,1-diphosphonic acid and from 0.5 to 10 moles of ethylenediamine disuccinic acid or a salt thereof per mole of 1-hydroxyethylidene-1,1-diphosphonic acid, wherein said adduct is in the form of a solid.",2014-01-14,0,0
"T-helper cell type 17 lineage-specific adjuvants, compositions and methods","The present invention relates to compositions and methods for the modulation of TN 17 responses. The invention provides compositions for the induction of TN 17 responses containing a TLR agonist and an apoptotic cell-associated agent or containing a microbe-infected apoptotic cell. The compositions of the present invention may also contain dendritic cells capable inducing TN 17 responses. In other embodiments, the invention provides compositions for the inhibition of TN 17 responses containing one or more blocking agents. Methods and compositions for the modulation of TN 17 responses and for the treatment of TN 17-associated diseases and for cancer are also provided.",2014-01-14,0,0
Gas sensor,"A gas sensor including a sensor element constituted by an oxygen-ion conductive solid electrolyte as a main component and detecting a predetermined gas component in a measurement gas includes: an external communication part having an opening opened to the outside, and introducing the measurement gas from the outside under a predetermined diffusion resistance; an internal space communicating with the external communication part; a first electrode formed on a surface of the internal space; a second electrode formed in a space different from the internal space; and a pumping cell operable to pump out oxygen existing in the internal space when a predetermined voltage is applied between the first electrode and the second electrode. The thickness of the external communication part is 50% or more and 100% or less of the thickness of the internal space.",2014-01-07,0,0
Pyrrolidine compounds which modulate the CB2 receptor,"Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain (I).",2014-01-14,0,1
Internal pipe coating inspection robot,"There is provided herein a robot-based electrical system for locating holidays within coated pipe that does not utilize a grounding wire. In a preferred arrangement, the robot will carry a metal rotating brush/capacitive pad combination and changes in the capacitance in the brush/pad circuit will be used to identify imperfections in the interior coating of the pipe and especially those located proximate a girth weld. In another preferred embodiment, a circumferential brush will be used that allows testing of the integrity of the internal coating throughout the length of the pipe as the robot travels the pipeline.",2014-01-21,0,0
Protein/peptide sequencing by chemical degradation in the gas phase,"A fast and sensitive method and device for protein sequencing are disclosed. The method uses a combination of Edman degradation chemistry and mass spectrometry to sequence proteins and polypeptides. A peptide degradation reaction is performed on a polypeptide or protein ion reactant in the gas phase. The reaction yields a first ion product corresponding to a first amino acid residue of the polypeptide or protein reactant and a polypeptide or protein fragment ion. The mass-to-charge ratio for the first ion product, or the polypeptide or protein fragment ion, or both, is then determined. The first amino acid residue of the polypeptide or protein reactant is then identified from the mass-to-charge ratio so determined.",2014-01-14,0,0
Complex pierced micromechanical part,"The invention relates to a method of fabricating a micromechanical part made of a single piece material. According to the invention, the method includes the following steps: a) forming a substrate which includes the negative cavity for said micromechanical part to be fabricated; b) forming a sacrificial layer on one portion of the substrate; c) depositing particles on the substrate intended to form a germ ination layer; d) removing the sacrificial layer so as to selectively leave one portion of the substrate free of any particles; e) depositing a layer of material by chemical vapour phase deposition so that the material is exclusively deposited where the particles remain; f) removing the substrate to release the micromechanical part formed in said negative cavity.",2014-01-28,0,0
Plant nucleic acids associated with cellular pH and uses thereof,"The present invention relates generally to the field of plant molecular biology and agents useful in the manipulation of plant physiological or biochemical properties. More particularly, the present invention provides genetic and proteinaceous agents capable of modulating or altering the level of acidity or alkalinity in a cell, group of cells, organelle, part or reproductive portion of a plant. Genetically altered plants, plant parts, progeny, subsequent generations and reproductive material including flowers or flowering parts having cells exhibiting an altered cellular pH compared to a non-genetically altered plant are also provided.",2014-01-14,0,0
Imaging agents for use in magnetic resonance blood flow/perfusion imaging,"In one aspect, a method of imaging blood flow in a region of interest of a subject using magnetic resonance imaging (MRI) is provided. The method includes introducing an imaging agent into the subject, the imaging agent including a compound having at least one hyperpolarized nucleus having a T.sub.1 greater than 15 seconds and a water-octanol partition coefficient between −1 and 1, providing at least one excitation signal to the region of interest, the at least one excitation signal configured to invoke a nuclear magnetic resonance (NMR) effect at least in the introduced imaging agent, and detecting an NMR signal emitted by the region of interest in response to the at least one excitation signal. In another aspect, the imaging agent includes a carbon-13 enriched alcohol.",2014-01-07,0,0
Mitotic kinesin inhibitors and methods of use thereof,"This invention relates to inhibitors of mitotic kinesins, particularly KSP, and methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing the inhibitors and pharmaceutical compositions in the treatment and prevention of various disorders.",2014-01-07,0,0
"Phosphoramide compound, method for producing the same, ligand, complex, catalyst and method for producing optically active alcohol","Disclosed is a method for highly efficiently obtaining an optically active alcohol from a carbonyl compound highly enantioselectively. Also disclosed is a ligand used in such a method. Specifically, an optically active alcohol is obtained by reacting a carbonyl compound and an organozinc compound by using a ligand (L) shown below.",2014-01-07,0,0
Allorestricted peptide-specific T cells,"The present invention is directed to a T cell receptor (TCR) recognizing antigenic peptides derived from tumor-associated antigen FMNL1/KW13 and being capable of inducing peptide specific killing of a target cell. The present invention is further directed to one antigenic peptides derived from tumor-associated antigen FMNL1/KW13, to an antigen specific T cell, comprising said TCR, to a nucleic acid coding for said TCR and to the use of the antigen specific T cells for the manufacture of a medicament for the treatment of malignancies characterized by overexpression of FMNL1/KW13.",2014-01-21,0,0
Screening method for GPCR ligands,"This invention relates to a method of identifying a compound capable of binding to a target domain of a G-protein coupled receptor comprising the steps of: (a) providing a receptor comprising said target domain and a first group linked to said target domain; (b) bringing into contact said receptor of (a) with a test molecule comprising a second group and said compound linked to each other, wherein said first group binds said second group; and (c) determining, subsequent to the binding of said first group to said second group, whether said compound binds to said target domain.",2014-01-07,0,0
High molecular weight derivatives of vitamin K-dependent polypeptides,"Modifications of vitamin K-dependent polypeptides that lead to enhanced protein function on a weight or molar basis and/or increase of protein lifetime in the circulation are described. Both objectives are important for using vitamin K-dependent polypeptides for pro- and anti-coagulation therapies, as well as for other uses in the circulation.",2014-01-21,0,0
Treatment of infected tissues with hypochlorous acid,"Super-oxidized water based on hypochlorous acid, such as is obtained by the electrochemical treatment of a saline solution, may be used in the treatment of leg ulcers or other open wounds. Preferably, the pH of the super-oxidized water is in a range of 4 to 7, and the water has a redox potential of >950 mV. Medicaments based on the super-oxidized water may be in liquid or gel form. The super-oxidized water is able to control the microbial population within the wound and at the same time permit cell proliferation.",2014-01-21,0,0
Method of forming an implantable knitted fabric comprising silk fibroin fibers,"Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.",2014-01-14,2,0
Combination therapy,"The present invention relates to a combination therapy for treating an HIV infection or inhibiting integrase comprising (S)-6-(3-Chloro-2-fluorobenzyl)-1-(1-hydroxymethyl-2-methylpropyl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (“Compound A”) or a pharmaceutically acceptable solvate or salt thereof in combination with at least one other anti-HIV agent. In some embodiments of the present invention, the other anti-HIV agents are chosen from reverse transcriptase inhibitors and protease inhibitors. In certain embodiments of the present invention, the other anti-HIV agents are chosen from AZT, 3TC, PMPA, efavirenz, indinavir, nelfinavir, a combination of AZT/3TC, and a combination of PMPA/3TC. Since Compound A has a high inhibitory activity specific for integrases, when used in combinations with other anti-HIV agents it can provide a combination therapy with fewer side effects for humans.",2014-01-21,0,0
Predicting possible outcomes in multi-factored diseases,"This disclosure relates, in general, to methods, systems, apparatus, computer programs and computing devices related to predicting possible outcomes in a multi-factored disease, disorder or condition.",2014-01-28,0,0
"Optical analysis system for dynamic, real-time detection and measurement","A system and a method for real-time processing and monitoring, the system including a light source to provide an illumination light and a calibration light are provided. The system includes an optical element to separate the illumination light and the calibration light; an optical element to direct the illumination light to a sample; an optical element to direct the calibration light to a first detector and a second detector; an optical element to collect light backscattered from the sample; an optical element to separate light backscattered from the sample into a first scattered light portion and a second scattered light portion; an optical element to direct the first scattered light portion through at least one multivariate optical element to the first detector; and an optical element to direct the second scattered light portion to the second detector.",2014-01-14,0,0
"Probe, polymorphism detection method, method of evaluating drug efficacy or tolerance, disease prediction method and reagent kit","A probe for detecting polymorphism in the ABCG2 gene is constituted by including, for example, an oligonucleotide which is complementary to a base sequence including the 301st to the 311th bases of the base sequence indicated in SEQ ID NO:1 and having a length of from 11 bases to 50 bases, and has an identity of at least 80%, and in which a base corresponding to the 311th base has been labeled with a fluorescent dye.",2014-01-07,0,0
"Micro-electro-mechanical systems (MEMS), systems, and operating methods thereof",A micro-electro-mechanical system (MEMS) includes a micro-mechanical structure that is capable of generating a first electrical signal. An analog-to-digital converter (ADC) is coupled with the micro-mechanical structure. The MEMS is free from including any amplifier between the micro-mechanical structure and the ADC.,2014-01-14,1,1
"Efficient isolation of cimiracemate A, and methods of use","A method for isolating cimiracemate A from a Cimicifuga species is disclosed, comprising the steps of a) providing a sufficient quantity of raw materials from the Cimicifuga species, b) mixing the raw materials from the Cimicifuga species with an aqueous polar solvent at a temperature of about 20° C. to about 28° C. to obtain a solvent extract comprising cimiracemate A, and c) isolating cimiracemate A from the solvent extract.",2014-01-21,0,0
"Displacement measurement method and apparatus thereof, stage apparatus, and probe microscope","A displacement measurement method, an apparatus thereof, and a probe microscope. which enable stable measure an amount of displacement and a moving distance of an object under measurement with an accuracy of the sub-nanometer order or below without being affected by disturbances such as fluctuations of air and mechanical vibration. A pulsed beam is split into two; one beam is reflected by an object under measurement and then inputted to a delay optical path equivalent to one pulse period; and the other beam is sent through the same delay optical path in the opposite direction up to the object under measurement with a delay of one pulse period, and then reflected by the object under measurement. An optical phase variation caused by the movement of the object under measurement is obtained by subjecting the two pulsed beams to interference.",2014-01-14,0,0
Process for producing a catalyst for the oxidation of ethylene to ethylene oxide,"The invention relates to a process for producing a catalyst for the oxidation of ethylene to ethylene oxide, which comprises a) providing a support which comprises alumina and has been impregnated with silver or with a silver-comprising compound and has a temperature T0; and b) heating the impregnated support from the temperature T0 to a temperature T1 at a heating rate of at least 30 K/min, and also the catalyst itself which can be obtained by this process.",2014-01-14,0,0
Method of forming micro-electrical-mechanical structure (MEMS),"A method of forming a micro-electrical-mechanical structure (MEMS), includes forming a plurality of electrodes on a substrate, forming a beam structure in electrical contact with a first of the electrodes, and bending the beam structure with a thermal process. The method further includes forming a cantilevered electrode extending over an end of the bent beam structure, and returning the beam structure to its original position, which will contact the cantilevered electrode in a normally closed position.",2014-01-28,0,0
Acylpiperazinones and their use as pharmaceuticals,"The invention relates to novel acylpiperazinone compounds, to the preparation of the compounds and intermediates used therein, to the use of the compounds as antibacterial medicaments and pharmaceutical compositions containing the compounds.",2014-01-07,0,0
Fiber probe based microfludic raman spectroscopy,A microfluidic device comprising at least one microfluidic channel with an input and an output for allowing fluid flow; and at least one Raman fiber based probe having an excitation fiber probe and/or a collection fiber probe positioned so that one end of the probe is in the microfluidic channel.,2014-01-28,0,0
S. aureus polypeptides and antibodies,"The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.",2014-01-21,0,0
Ultrafast electron diffraction device,"An ultrafast electron diffraction device for irradiating a sample with a bunch of electrons in an ultrashort pulse in order to perform an ultrafast analysis of the sample. The ultrafast electron diffraction device includes: a) a laser emitter for delivering an ultrashort pulse laser having a pulse width of not more than 1 ps onto a target which is a material for generating electrons at an intensity of not less than 1017 W/cm2; and b) a pulse compressor for rotating, in a magnetostatic field, a bunch of electrons generated from the target onto which the ultrashort pulse laser has been delivered so as to suppress the spread of the bunch of electrons in their traveling direction. The pulse compressor is composed of an entrance-side parallel-plate static magnet, one end of which is placed on the course of the bunch of electrons, and an exit-side parallel-plate static magnet.",2014-01-21,0,0
Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes,"Hybrid molecules comprising CD4 minimal modules or mimetics that bind to HIV Env polypeptides in combination with one or more HIV Tat polypeptides are described. Also described are complexes of these hybrid molecules with Env as well as methods of diagnosis, treatment and prevention using the polynucleotides and polypeptides.",2014-01-28,0,0
Movement detection device for detecting movement of object in space range,"The present invention relates to a movement detection device for detecting a movement of an object in a space range. The movement detection device includes a light source, a light guiding element, at least two light sensing elements and a processing unit. The light sensing elements have an offset therebetween along a first direction such that the object, when moving in the space range, reflects the light from the light source sequentially to the light sensing elements through the light guiding element. The processing unit identifies the movement of the object along the first direction according to a sequence that the light sensing elements detect the light reflected by the object.",2014-01-21,0,0
Methods of inspecting structures,"A method of inspecting a structure. The method includes preparing preliminary spectrums of reference diffraction intensities according to critical dimensions of reference structures, obtaining a linear spectrum from the preliminary spectrums in a set critical dimension range, radiating light to respective measurement structures formed on a substrate, measuring measurement diffraction intensities of the light diffracted by the measurement structures, and obtaining respective critical dimensions of the measurement structures from the measurement diffraction intensities using the linear spectrum.",2014-01-07,0,0
Aqueous hair cleansing agent,"An aqueous hair cleansing agent contains a sulfate-type anionic surfactant having a specific structure, an ether carboxylate-type anionic surfactant having a specific structure, and an organic carboxylic acid or salt thereof, thereby has a pH of 1 to 5 at 25° C. when diluted 20-fold with water.",2014-01-21,0,0
Compositions and methods for the intraocular transport of therapeutic agents,Membrane transporter-targeted therapeutic agents and methods of making and using the same.,2014-01-28,0,0
Nucleoside phosphoramidates,"Disclosed herein are nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent 5 RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals.",2014-01-21,1,0
Systems and methods for automated analysis of cells and tissues,"Systems and methods for rapidly analyzing cell containing samples, for example to identify morphology or to localize and quantitate biomarkers are disclosed.",2014-01-28,0,0
Compositions for immunising against Staphylococcus aureus ,"Staphylococcus aureus Hla polypeptides having various deletions, insertions, and/or mutations which are useful for immunization are provided herein. Also provided herein are Hla heptamers which are non-haemolytic. Additionally, an effective Staphylococcus aureus vaccine may require several antigenic components, and so various combinations of S. aureus antigens, including Hla polypeptides having deletions, insertions, and/or mutations, are identified for use in immunization. These polypeptides may optionally be used in combination with S. aureus saccharides.",2014-01-21,0,0
Dual specificity antibody fusions,"The present invention provides dual specificity antibody fusion proteins comprising an antibody Fab or Fab′ fragment with specificity for an antigen of interest, the fragment being fused to at least one single domain antibody which has specificity for a second antigen of interest.",2014-01-14,0,0
